Thrombosis Research
Volume 126, Issue 1 , Pages 12-17, July 2010

Small intestinal bacterial overgrowth and warfarin dose requirement variability

  • Vittorio Giuliano

      Affiliations

    • Gastrointestinal and Hepatology Section, Department of Clinical and Experimental Medicine, Italy
    • Corresponding Author InformationCorresponding author. Gastrointestinal and Hepatology Section, Department of Clinical and Experimental Medicine, Ospedale S. Maria della Misericordia, S.Andrea delle Fratte, 06132 Perugia Italy.
  • ,
  • Gabrio Bassotti

      Affiliations

    • Gastrointestinal and Hepatology Section, Department of Clinical and Experimental Medicine, Italy
  • ,
  • Evangelia Mourvaki

      Affiliations

    • Internal and Vascular Medicine Section, Department of Internal Medicine, Italy
  • ,
  • Danilo Castellani

      Affiliations

    • Gastrointestinal and Hepatology Section, Department of Clinical and Experimental Medicine, Italy
  • ,
  • Esmeralda Filippucci

      Affiliations

    • Internal and Vascular Medicine Section, Department of Internal Medicine, Italy
  • ,
  • Giuseppe Sabatino

      Affiliations

    • Gastrointestinal and Hepatology Section, Department of Clinical and Experimental Medicine, Italy
  • ,
  • Stefania Gizzi

      Affiliations

    • Gastrointestinal and Hepatology Section, Department of Clinical and Experimental Medicine, Italy
  • ,
  • Francesco Palmerini

      Affiliations

    • Internal and Vascular Medicine Section, Department of Internal Medicine, Italy
  • ,
  • Francesco Galli

      Affiliations

    • Department of Biochemistry Science and Molecular Biotechnologies, University of Perugia, Italy
  • ,
  • Olivia Morelli

      Affiliations

    • Gastrointestinal and Hepatology Section, Department of Clinical and Experimental Medicine, Italy
  • ,
  • Monia Baldoni

      Affiliations

    • Gastrointestinal and Hepatology Section, Department of Clinical and Experimental Medicine, Italy
  • ,
  • Antonio Morelli

      Affiliations

    • Gastrointestinal and Hepatology Section, Department of Clinical and Experimental Medicine, Italy
  • ,
  • Alfonso Iorio

      Affiliations

    • Internal and Vascular Medicine Section, Department of Internal Medicine, Italy

Received 15 April 2009; received in revised form 13 October 2009; accepted 25 November 2009. published online 22 February 2010.

Abstract 

The dose of warfarin needed to obtain a therapeutic anticoagulation level varies widely among patients and can undergo abrupt changes for unknown reasons. Drug interactions and genetic factors may partially explain these differences. Intestinal flora produces vitamin K2 (VK2) and patients with small intestinal bacterial overgrowth (SIBO) rarely present reduced INR values due to insufficient dietary vitamin K. The present study was undertaken to investigate whether SIBO occurrence may affect warfarin dose requirements in anticoagulated patients. Based on their mean weekly dose of warfarin while on stable anticoagulation, 3 groups of 10 patients each were defined: low dose (LD, ≤17.5mg/wk of warfarin); high dose (HD, from 35-70mg/wk); and very high dose (VHD ≥70mg/wk). Each patient underwent a lactulose breath test to diagnose SIBO. Plasma levels of warfarin and vitamin K-analogues were also assessed. Patients with an altered breath test were 50% in the VHD group, 10% in the HD group, and none in the LD group (P=0.01). Predisposing factors to SIBO were more frequent in the VHD group, while warfarin interfering variables were not. VHD patients were younger and had a higher plasma vitamin K1 (VK1) concentration (P>0.05). On the contrary, the plasma VK2 levels tended to be lower. This pilot study suggests that SIBO may increase a patient's warfarin dose requirement by increasing dietary VK1 absorption through the potentially damaged intestinal mucosa rather than increasing intestinal VK2 biosynthesis. Larger studies are needed to confirm these preliminary data and to evaluate the effects of SIBO decontamination on warfarin dosage.

Abbreviations: SIBO, small intestinal bacterial overgrowth, VK2, vitamin K2 or menaquinone, LD, low dose, HD, high dose, VHD, very high dose, VK1, vitamin K1 or phyloquinone, VKAs, vitamin K antagonists, INR, International Normalized Ratio, LBT, lactulose breath test, PPI, proton pump inhibitors, MKs, menaquinone-n, OR, odds ratio, CI, confidence interval, BMI, body mass index, SEM, standard error of the mean

Keywords: Anticoagulants, Bacterial overgrowth, Lactulose breath test, Menaquinone, Phylloquinone, Warfarin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0049-3848(09)00547-7

doi:10.1016/j.thromres.2009.11.032

Thrombosis Research
Volume 126, Issue 1 , Pages 12-17, July 2010